Q4 2024 EPS Estimates for Aspen Aerogels, Inc. (NYSE:ASPN) Decreased by Analyst

Aspen Aerogels, Inc. (NYSE:ASPN) – Analysts at Roth Capital lowered their Q4 2024 earnings estimates for Aspen Aerogels in a note issued to investors on Friday, May 3rd. Roth Capital analyst C. Moore now forecasts that the construction company will earn ($0.01) per share for the quarter, down from their prior forecast of $0.03. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.03 per share.

A number of other brokerages also recently weighed in on ASPN. Roth Mkm reaffirmed a “buy” rating and set a $22.00 price objective on shares of Aspen Aerogels in a research report on Tuesday, April 30th. TheStreet upgraded shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. Piper Sandler increased their target price on shares of Aspen Aerogels from $20.00 to $29.00 and gave the company an “overweight” rating in a research report on Friday. HC Wainwright lifted their price target on shares of Aspen Aerogels from $20.00 to $25.00 and gave the stock a “buy” rating in a report on Friday. Finally, B. Riley increased their price objective on Aspen Aerogels from $24.00 to $30.00 and gave the company a “buy” rating in a report on Friday. One research analyst has rated the stock with a sell rating and six have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $25.17.

Aspen Aerogels Trading Up 3.1 %

Shares of NYSE:ASPN opened at $25.90 on Monday. The company has a market capitalization of $1.97 billion, a PE ratio of -58.86 and a beta of 1.97. The company has a current ratio of 4.01, a quick ratio of 3.29 and a debt-to-equity ratio of 0.24. Aspen Aerogels has a 12-month low of $5.32 and a 12-month high of $25.91. The business’s fifty day simple moving average is $16.90 and its 200-day simple moving average is $13.90.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Tuesday, February 13th. The construction company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.11. The firm had revenue of $84.22 million for the quarter, compared to the consensus estimate of $83.82 million. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. During the same period last year, the firm earned ($0.20) earnings per share.

Institutional Trading of Aspen Aerogels

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Banque Cantonale Vaudoise grew its holdings in Aspen Aerogels by 37.5% in the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after purchasing an additional 1,252 shares during the last quarter. McAdam LLC acquired a new stake in Aspen Aerogels in the 4th quarter valued at about $191,000. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Aspen Aerogels by 38.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after acquiring an additional 3,607 shares in the last quarter. Cornerstone Investment Partners LLC acquired a new position in Aspen Aerogels during the fourth quarter worth about $230,000. Finally, Raymond James Financial Services Advisors Inc. purchased a new stake in shares of Aspen Aerogels in the fourth quarter valued at about $265,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.